To the Editor,
Recently, we cared for a 5-month-old baby boy born at 28 weeks gestation with a 1.9-mm patent ductus arteriosus (Fig 1). The parents were counselled regarding the plan for percutaneous device closure and asked to return 2 weeks later. Surprisingly, on repeat echocardiogram, the ductus arteriosus had closed.
As spontaneous ductal closure is unusual past the newborn period, we questioned the parents about the events in the preceding 2 weeks. The parents reported administering paracetamol 12 mg/kg/dose twice daily for 4 days because of fussiness and nasal congestion. In premature infants during the newborn period, indomethacin or ibuprofen are first-line agents utilised for ductal closure. In patients with contraindications to non-steroidal anti-inflammatory drugs, paracetamol at 15 mg/kg/dose every 6 hours for 48 hours has been used effectively as a second-line agent.Reference Allegaert, Anderson, Simons and van Overmeire 1 , Reference Hammerman, Bin-Nun, Markovitch, Schimmel, Kaplan and Fink 2 Previous authors have suggested that paracetamol works by acting at the peroxidase segment of prostaglandin synthetase and inhibits activity.Reference Lucas, Warner, Vojnovic and Mitchell 3
To the best of our knowledge, our case is the first reported case of ductal closure associated with paracetamol outside of the newborn period. Further studies are needed to elucidate the role of paracetamol for ductal closure beyond the neonatal period.
Acknowledgements
C.H. drafted the initial manuscript, conducted the literature search, revised subsequent versions of the manuscript, and approved the final manuscript as submitted. G.G. performed the literature search, revised subsequent versions of the manuscript, and approved the final manuscript as submitted. M.E. revised subsequent versions of the manuscript and approved the final manuscript as submitted. M.U. revised subsequent versions of the manuscript and approved the final manuscript as submitted.
Financial Support
This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.
Conflicts of Interest
None.
Ethical Standards
The manuscript is original and has not been accepted or published elsewhere.